Vitamin D Supplementation for Preterm and Low Birth Weight Babies

Supplementation Effects on Preterm and Low Birth Weight Infants

Infants born preterm before 37 weeks of gestation or weighing less than 2,500 grams face distinct nutritional hurdles. Vitamin D is essential because it helps the body absorb calcium from food, which drives bone development and strength. Without sufficient intake, infants risk developing rickets, a condition where bones become thin, brittle, or misshapen. Newborns often lack adequate sunlight exposure, and human milk alone may not supply enough of the nutrient. Target blood levels sit between 50 and 250 nanomoles per litre, with insufficiency defined as under 50 nmol/L and deficiency under 30 nmol/L. According to the evidence review, giving vitamin D supplements versus no supplementation across 11 studies of 1,514 preterm babies probably reduces the risk of vitamin D deficiency, benefiting about one in every four babies supplemented. It may also reduce insufficiency, benefiting one in every three. A separate study of 2,079 near-term, low birthweight babies showed that supplementation similarly cuts deficiency and insufficiency rates by one in three at six months of age.

Comparing Higher Versus Lower Daily Doses

When evaluating dosage variations, researchers analyzed 25 studies involving 1,546 preterm infants to contrast higher doses of 800 international units per day or more against lower doses ranging from 200 to less than 800 international units daily. Higher doses probably reduce the risk of deficiency—benefiting one in every eight babies supplemented—and may lower insufficiency rates compared to lower regimens. Yet that benefit comes with a trade-off regarding upper safety limits. Higher daily doses probably lead to unhealthily high vitamin D levels, harming approximately one in every 25 babies supplemented. Excess vitamin D exceeding 250 nmol/L can trigger unwanted effects, including high blood calcium levels and kidney stones. While higher doses may improve bone health blood markers, review findings indicate little to no difference in bone appearance on X-rays.

Hospital Disparities and Future Research Needs

Separate observational findings from a study underline how widespread low status is during initial hospital stays. Researchers evaluated 120 infants born at or below 32 weeks gestation across multiple medical centers and found that mean serum levels at birth sat at 46.2 nmol/L. Concentrations were notably lower in infants born under 28 weeks compared to those born between 28 and 32 weeks gestation. That study observed that 64 percent of infants at birth and 35 percent at hospital discharge had serum concentrations below 50 nmol/L. Investigators concluded that current nutritional strategies in neonatal intensive care units may be insufficient to achieve recommended targets. Future studies must investigate optimal, weight-based dosing regimens while reporting outcomes such as bone health.